Tuesday, 22 September 2009

Ranbaxy Lab can go upto Rs 420-425: Gujral

Ranbaxy Laboratories can go upto Rs 420-425, says Technical Analyst, Ashwani Gujral.

Gujral told CNBC-TV18, "Ranbaxy seems to have bottomed out and that could be headed towards Rs 420-425. Dr Reddys Laboratories has sort of consolidated and because of some rumours that started a fresh move, so here we could get to level of about Rs 920-925. So, pharma overall is looking strong. The point is that as long as this rotational game continues the market will remain strong but it’s getting overbought and nobody is negative, so people need to get into habit of taking profits now."

Source: Moneycontrol

No comments:

Post a Comment

DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.